8th Annual Immuno-Oncology Innovation Forum

Following the success of last year’s event, we are pleased to announce, our 8th Annual Immuno-Oncology Innovation Forum (#Sachs_IOIF) which will take place virtually on the 24th-25th of May 2022.

Due to the pandemic, the #Sachs_IOIF event will be once again hosted in a digital format. This will allow us to further support our community and past attendees, bridging Europe and the US. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system.

The programme for the 8th Annual IOIF will be spread throughout 2 days. Featuring more than 12 hours of keynotes, high-level speeches, panel discussions and spotlight showcases by leading corporates. The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharma’s and biotech’s.

We anticipate over 300 delegates and 25+ company presentations by established listed, private and emerging companies. Over half of these attendees are corporate and financial investors, analysts, bankers and advisors.